On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
On Mar. 25, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
On Mar. 23, 2020, researchers from the University of Oxford announced they have launched a new clinical trial…
On Mar. 20, 2020, Amneal Pharmaceuticals, one of the largest U.S.-based generics manufacturers, announced that it is responding to…
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
On Mar. 13, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical Companies have entered a collaboration with…
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
On Mar. 2, 2020, Ophirex, a public-benefit biotechnology company working to improve outcomes for global victims of snakebite,…
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…
On Feb. 25, 2020, a University of British Columbia (UBC) researcher was part of an international team working…
On Feb. 24, 2020, Innovation Pharmaannounced the Company submitted a Material Transfer Agreement (MTA) with a leading U.S.-based…
On Feb. 22, 2020, a federal judge from the Southern District of New York ruled drug companies, device…
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
On Feb. 18, 2020, Innovation Pharma announced the Company was exploring its lead defensin mimetic drug candidate, Brilacidin,…
On Feb. 16, 2020, Medigen Vaccine Biologics (MVB) and the National Institutes of Health (NIH) announced they had…
On Dec. 25, 2019, Medigen Vaccine Biologics (MVB) announced it had completed the enrollment of phase III multi-region…
On Dec. 20, 2019, Vaccitech’s partner, the University of Oxford’s Jenner Institute, in collaboration with The King Abdullah…
On Dec. 17, 2019, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that Gregory Friedman,…
On Dec. 16, 2019, researchers at the National Eye Institute launched a clinical trial to test the safety…
On Dec. 11, 2019, Dennis Eggers became the first patient in a new clinical trial to receive a…
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
On Jun. 20, 2025, CanSino Biologics announced that it had received the National Medical Products Administration’s (NMPA) permission…
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
On Dec. 5, 2018, Genomics England announced the 100,000 Genomes Project, done in partnership with National Health Service…
On Oct. 3, 2018, Scripps Research announced that Calibr scientitsts from Scripp’s drug development division had begun using…
May 4, 2018, scientists from the National Cancer Institute (NCI) reported that an analysis of a prevention clinical…